Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Färkkilä, Markus ; Diener, Hans-Christoph ; Géraud, Gilles ; Láinez, Miguel ; Schoenen, Jean ; Harner, Nadja ; Pilgrim, Alison ; Reuter, Uwe
Lancet neurology, 2012-05, Vol.11 (5), p.405-413 [Revista revisada por pares]England: The Lancet Publishing Group
Texto completo disponible